These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19160695)

  • 1. Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.
    Van der Kwast TH; Zlotta AR; Fleshner N; Jewett M; Lopez-Beltran A; Montironi R
    Anal Quant Cytol Histol; 2008 Dec; 30(6):309-15. PubMed ID: 19160695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas.
    Eble JN; Young RH
    Semin Diagn Pathol; 1989 Nov; 6(4):351-71. PubMed ID: 2692107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New WHO classification of urothelial carcinoma of the urinary bladder].
    Helpap B
    Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological diagnosis of urothelial neoplasms.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
    J Clin Pathol; 2008 Jan; 61(1):3-10. PubMed ID: 17545560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of upper tract urothelial carcinoma with emphasis on staging.
    Mazzucchelli R; Scarpelli M; Galosi AB; Di Primio R; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2014; 27(4):509-16. PubMed ID: 25572730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts.
    Jones TD; Cheng L
    J Urol; 2006 Jun; 175(6):1995-2003. PubMed ID: 16697785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
    Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
    Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
    Helpap B; Köllermann J
    Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.